The cardiovascular safety of sodium nitroprusside in acute heart failure

References

• Navaza A, Chevrier G, Alzari PM, et al. Single-crystal neutron diffraction structure of sodium pentacyanonitrosylferrate(2-) (sodium nitroprusside) dihydrate”. Acta Crystallogr C. 1989;45(6):839–841. doi: 10.1107/S0108270188013691
   Google Scholar
• Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest. 1986;78(1):1–5. doi: 10.1172/JCI112536
   PubMed Web of Science ®Google Scholar
• Szadujkis-Szadurska K, Grzesk G, Szadujkis-Szadurski L, et al. Role of nitric oxide and cGMP in the modulation of vascular contraction induced by angiotensin II and bay K8644 during ischemia/reperfusion. Exp Ther Med. 2013;5(2):616–620. doi: 10.3892/etm.2012.846
   PubMed Web of Science ®Google Scholar
• Grześk E, Malinowski E, Tejza B. Modulatory effect of sodium nitroprusside and 8Br-cGMP on mastoparan-7 induced contraction. Med Biol Sci. 2014;28(4):31–35. doi: 10.12775/MBS.2014.031
   Google Scholar
• Butler J, Usman MS, Anstrom KJ, et al. Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum. Eur J Heart Fail. 2022;24(11):2029–2036. doi: 10.1002/ejhf.2720
   PubMed Web of Science ®Google Scholar
• Page IH, Corcoran AC, Dustan HP, et al. Cardiovascular actions of sodium nitroprusside in animals and hypertensive patients. Circulation. 1955;11(2):188–198. doi: 10.1161/01.CIR.11.2.188
   PubMed Web of Science ®Google Scholar
• Berkowitz C, McKeever L, Croke RP, et al. Comparative responses to dobutamine and nitroprusside in patients with chronic low output cardiac failure. Circulation. 1977;56(6):918–924. doi: 10.1161/01.CIR.56.6.918
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Abraham WT, Albert NM, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006;296(18):2217–2226. doi: 10.1001/jama.296.18.2217
   PubMed Web of Science ®Google Scholar
• Bastos MB, Burkhoff D, Maly J, et al. Invasive left ventricle pressure-volume analysis: overview and practical clinical implications. Eur Heart J. 2020;41(12):1286–1297. doi: 10.1093/eurheartj/ehz552
   PubMed Web of Science ®Google Scholar
• Ikonomidis I, Aboyans V, Blacher J, et al. The role of ventricular-arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and heart failure association. Eur J Heart Fail. 2019;21(4):402–424. doi: 10.1002/ejhf.1436
   PubMed Web of Science ®Google Scholar
• Capomolla S, Pozzoli M, Opasich C, et al. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function. Am Heart J. 1997;134(6):1089–1098. doi: 10.1016/S0002-8703(97)70030-9
   PubMed Web of Science ®Google Scholar
• Garatti L, Frea S, Bocchino PP, et al. Sodium nitroprusside in acute heart failure: A multicenter historic cohort study. Int J Cardiol. 2022;369:37–44. doi: 10.1016/j.ijcard.2022.08.009
   PubMed Web of Science ®Google Scholar
• Schwartzenberg S, Redfield MM, From AM, et al. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy. J Am Coll Cardiol. 2012;59(5):442–451. doi: 10.1016/j.jacc.2011.09.062
   PubMed Web of Science ®Google Scholar
• Mullens W, Abrahams Z, Francis GS, et al. Sodium nitroprusside for advanced low-output heart failure. J Am Coll Cardiol. 2008;52(3):200–207. doi: 10.1016/j.jacc.2008.02.083
   PubMed Web of Science ®Google Scholar
• Mann T, Cohn PF, Holman LB, et al. Effect of nitroprusside on regional myocardial blood flow in coronary artery disease. Results in 25 patients and comparison with nitroglycerin. Circulation. 1978;57(4):732–738. doi: 10.1161/01.CIR.57.4.732
   PubMed Web of Science ®Google Scholar
• Cohn JN, Franciosa JA, Francis GS, et al. Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration cooperative study. N Engl J Med. 1982;306(19):1129–1135. doi: 10.1056/NEJM198205133061902
   PubMed Web of Science ®Google Scholar
• De Backer O, Debonnaire P, Gevaert S, et al. Prevalence, associated factors and management implications of left ventricular outflow tract obstruction in takotsubo cardiomyopathy: a two-year, two-center experience. BMC Cardiovasc Disord. 2014;14(1):147. doi: 10.1186/1471-2261-14-147
   PubMedGoogle Scholar
• Kapelios CJ, Shahim B, Lund LH, et al. Epidemiology, clinical characteristics and cause-specific outcomes in heart failure with preserved ejection fraction. Card Fail Rev. 2023;9:e14. doi: 10.15420/cfr.2023.03
   PubMedGoogle Scholar
• Ali D, Tran P, Ennis S, et al. Rising arterial stiffness with accumulating comorbidities associates with heart failure with preserved ejection fraction. ESC Heart Fail. 2023;10(4):2487–2498. doi: 10.1002/ehf2.14422
   PubMed Web of Science ®Google Scholar
• Tinker JH, Michenfelder JD. Sodium nitroprusside: pharmacology, toxicology and therapeutics. Anesthesiology. 1976;45(3):340–354. doi: 10.1097/00000542-197609000-00016
   PubMed Web of Science ®Google Scholar
• Friederich JA, Butterworth JF. Sodium nitroprusside: twenty years and counting. Anesth Analg. 1995 4th;81(1):152–162. doi: 10.1097/00000539-199507000-00031
   PubMed Web of Science ®Google Scholar
• Bocchino PP, Cingolani M, Frea S, et al. Organ perfusion pressure at admission and clinical outcomes in patients hospitalized for acute heart failure. Eur Heart J Acute Cardiovasc Care. 2023 Oct 26;44(Supplement_2):zuad133. doi: 10.1093/eurheartj/ehad655.1090
   Google Scholar
• Bocchino PP, Angelini F, Frea S. Intravenous vasodilators in acute heart failure patients with low basic blood pressure: may the benefit come from targeting perfusion rather than pressure? Eur Heart J. 2020;41(25):2409–2410. doi: 10.1093/eurheartj/ehaa372
   PubMed Web of Science ®Google Scholar